EyeGene Inc. (KOSDAQ:185490)
South Korea
· Delayed Price · Currency is KRW
1,952.00
+2.00 (0.10%)
At close: Dec 5, 2025
EyeGene Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 52,762 | 69,196 | 91,605 | 108,036 | 408,921 | 148,527 | |
| Market Cap Growth | -35.26% | -24.46% | -15.21% | -73.58% | 175.32% | 11.93% | |
| Enterprise Value | 29,268 | 38,542 | 52,919 | 41,816 | 313,462 | 127,760 | |
| Last Close Price | 1952.00 | 2190.98 | 3650.20 | 4304.93 | 16346.74 | 8274.82 | |
| PS Ratio | 12.86 | 20.62 | 29.31 | 20.41 | 126.13 | 44.16 | |
| PB Ratio | 1.15 | 1.32 | 1.40 | 1.57 | 4.60 | 11.51 | |
| P/TBV Ratio | 1.36 | 1.50 | 1.47 | 1.64 | 4.64 | 11.97 | |
| EV/Sales Ratio | 7.13 | 11.49 | 16.93 | 7.90 | 96.68 | 37.99 | |
| Debt / Equity Ratio | 0.01 | 0.05 | 0.03 | 0.04 | 0.04 | 1.33 | |
| Asset Turnover | 0.07 | 0.05 | 0.04 | 0.06 | 0.04 | 0.07 | |
| Inventory Turnover | 5.63 | 6.90 | 4.56 | 4.10 | 2.40 | 3.59 | |
| Quick Ratio | 3.91 | 3.64 | 6.81 | 13.79 | 8.99 | 3.92 | |
| Current Ratio | 4.02 | 3.75 | 6.88 | 13.99 | 9.23 | 4.26 | |
| Return on Equity (ROE) | -19.63% | -21.89% | -33.39% | -33.55% | -67.87% | -93.10% | |
| Return on Assets (ROA) | -9.01% | -11.55% | -21.36% | -16.24% | -29.28% | -18.63% | |
| Return on Capital (ROIC) | -10.80% | -13.54% | -24.38% | -18.33% | -35.59% | -25.42% | |
| Return on Capital Employed (ROCE) | -18.10% | -23.70% | -38.80% | -31.90% | -36.70% | -38.10% | |
| Earnings Yield | -18.32% | -17.53% | -23.04% | -24.02% | -8.45% | -10.01% | |
| FCF Yield | -10.54% | -19.78% | -23.48% | -17.90% | -7.92% | -7.94% | |
| Buyback Yield / Dilution | -46.90% | -24.87% | -0.94% | -13.22% | -36.98% | -3.62% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.